Test & Treat

Access to effective oral treatments for COVID-19, especially for high-risk populations and those without access to vaccination, can help save lives and limit the impact of future surges. But these therapies require access to accurate, rapid tests to be most valuable, and challenges remain on supply, demand, and financing for both tests and oral therapies. In our recent report, Pills to People, we lay out key recommendations to enable more equitable global access to oral therapies and support implementation of test-and-treat strategies.